We serve Chemical Name:8-Bromoacetylquinoline hydrobromide CAS:859962-48-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:8-Bromoacetylquinoline hydrobromide
CAS.NO:859962-48-4
Synonyms:8-(Bromoacetyl)quinoline.HBr;8-(Bromoacetyl)quinoline hydrobromide
Molecular Formula:C11H9Br2NO
Molecular Weight:331.00300
HS Code:2933499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:392.2ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:29.96000
Exact Mass:328.90500
LogP:3.77050
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 8-(Bromoacetyl)quinoline.HBr chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-(Bromoacetyl)quinoline hydrobromide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-(Bromoacetyl)quinoline hydrobromide Use and application,8-(Bromoacetyl)quinoline.HBr technical grade,usp/ep/jp grade.
Related News: Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production. 8-Bromoacetylquinoline hydrobromide manufacturer Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes. 8-Bromoacetylquinoline hydrobromide supplier Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. 8-Bromoacetylquinoline hydrobromide vendor By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 8-Bromoacetylquinoline hydrobromide factory By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.
